Resveratrol prevents high glucose-induced epithelial-mesenchymal transition in renal tubular epithelial cells by inhibiting NADPH oxidase/ROS/ERK pathway

Molecular and Cellular Endocrinology

Volumn 402, Issue , 2015, Pages 13-20

  He, Ting ^a   Guan, Xu ^a   Wang, Song ^a   Xiao, Tangli ^a   Yang, Ke ^a   Xu, Xinli ^a   Wang, Junping ^a   Zhao, Jinghong ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Diabetic nephropathy; Epithelial mesenchymal transition; Extracellular signal regulated kinase 1 2; Reactive oxygen species; Resveratrol

Indexed keywords

DIPHENYLIODONIUM SALT; GLUCOSE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; RESVERATROL; ANTIOXIDANT; NOX1 PROTEIN, HUMAN; NOX4 PROTEIN, HUMAN; STILBENE DERIVATIVE;

ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; IN VITRO STUDY; KIDNEY TUBULE CELL; SIGNAL TRANSDUCTION; UPREGULATION; ANTAGONISTS AND INHIBITORS; CELL LINE; DIABETIC NEPHROPATHIES; DRUG EFFECTS; DRUG SCREENING; EPITHELIUM CELL; KIDNEY; KIDNEY TUBULE; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANTIOXIDANTS; CELL LINE; DIABETIC NEPHROPATHIES; DRUG EVALUATION, PRECLINICAL; EPITHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; GLUCOSE; HUMANS; KIDNEY; KIDNEY TUBULES; MAP KINASE SIGNALING SYSTEM; NADPH OXIDASE; REACTIVE OXYGEN SPECIES; STILBENES;

EID: 84920911324     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2014.12.010     Document Type: Article

References (49)

1. Afkarian M., Sachs M.C., Kestenbaum B., Hirsch I.B., Tuttle K.R., Himmelfarb J., et al. Kidney disease and increased mortality risk in type 2 diabetes. J. Am. Soc. Nephrol 2013, 24:302-308.
2. Al-Awwadi N.A., Araiz C., Bornet A., Delbosc S., Cristol J.P., Linck N., et al. Extracts enriched in different polyphenolic families normalize increased cardiac NADPH oxidase expression while having differential effects on insulin resistance, hypertension, and cardiac hypertrophy in high-fructose-fed rats. J. Agric. Food Chem 2005, 53:151-157.
3. Bedard K., Krause K.H. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol. Rev 2007, 87:245-313.
4. Burns W.C., Twigg S.M., Forbes J.M., Pete J., Tikellis C., Thallas-Bonke V., et al. Connective tissue growth factor plays an important role in advanced glycation end product-induced tubular epithelial-to-mesenchymal transition: implications for diabetic renal disease. J. Am. Soc. Nephrol 2006, 17:2484-2494.
5. Carew R.M., Wang B., Kantharidis P. The role of EMT in renal fibrosis. Cell Tissue Res 2012, 347:103-116.
6. Chen F., Qian L.H., Deng B., Liu Z.M., Zhao Y., Le Y.Y. Resveratrol protects vascular endothelial cells from high glucose-induced apoptosis through inhibition of NADPH oxidase activation-driven oxidative stress. CNS Neurosci. Ther 2013, 19:675-681.
7. Chen J., Chen J.K., Harris R.C. Angiotensin II induces epithelial-to-mesenchymal transition in renal epithelial cells through reactive oxygen species/Src/caveolin-mediated activation of an epidermal growth factor receptor-extracellular signal-regulated kinase signaling pathway. Mol. Cell. Biol 2012, 32:981-991.
8. Dworakowski R., Alom-Ruiz S.P., Shah A.M. NADPH oxidase-derived reactive oxygen species in the regulation of endothelial phenotype. Pharmacol. Rep 2008, 60:21-28.
9. Eddy A.A. Molecular insights into renal interstitial fibrosis. J. Am. Soc. Nephrol 1996, 7:2495-2508.
10. Fagone E., Conte E., Gili E., Fruciano M., Pistorio M.P., Lo Furno D., et al. Resveratrol inhibits transforming growth factor-beta-induced proliferation and differentiation of ex vivo human lung fibroblasts into myofibroblasts through ERK/Akt inhibition and PTEN restoration. Exp. Lung Res 2011, 37:162-174.
11. Forbes J.M., Coughlan M.T., Cooper M.E. Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes 2008, 57:1446-1454.
12. Gilbert R.E., Cooper M.E. The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury?. Kidney Int 1999, 56:1627-1637.
13. Gill P.S., Wilcox C.S. NADPH oxidases in the kidney. Antioxid. Redox Signal 2006, 8:1597-1607.
14. Ha H., Lee H.B. Reactive oxygen species amplify glucose signalling in renal cells cultured under high glucose and in diabetic kidney. Nephrology (Carlton) 2005, 10(Suppl.):S7-S10.
15. Ha H., Yu M.R., Choi Y.J., Lee H.B. Activation of protein kinase c-delta and c-epsilon by oxidative stress in early diabetic rat kidney. Am. J. Kidney Dis 2001, 38:S204-S207.
16. Hasegawa K., Wakino S., Simic P., Sakamaki Y., Minakuchi H., Fujimura K., et al. Renal tubular Sirt1 attenuates diabetic albuminuria by epigenetically suppressing Claudin-1 overexpression in podocytes. Nat. Med 2013, 19:1496-1504.
17. He X., Wang Y., Zhu J., Orloff M., Eng C. Resveratrol enhances the anti-tumor activity of the mTOR inhibitor rapamycin in multiple breast cancer cell lines mainly by suppressing rapamycin-induced AKT signaling. Cancer Lett 2011, 301:168-176.
18. Iwano M., Neilson E.G. Mechanisms of tubulointerstitial fibrosis. Curr. Opin. Nephrol. Hypertens 2004, 13:279-284.
19. Jang J.H., Surh Y.J. Protective effects of resveratrol on hydrogen peroxide-induced apoptosis in rat pheochromocytoma (PC12) cells. Mutat. Res 2001, 496:181-190.
20. Jimenez R., Lopez-Sepulveda R., Kadmiri M., Romero M., Vera R., Sanchez M., et al. Polyphenols restore endothelial function in DOCA-salt hypertension: role of endothelin-1 and NADPH oxidase. Free Radic. Biol. Med 2007, 43:462-473.
21. Kalluri R., Neilson E.G. Epithelial-mesenchymal transition and its implications for fibrosis. J. Clin. Invest 2003, 112:1776-1784.
22. Kim M.Y., Lim J.H., Youn H.H., Hong Y.A., Yang K.S., Park H.S., et al. Resveratrol prevents renal lipotoxicity and inhibits mesangial cell glucotoxicity in a manner dependent on the AMPK-SIRT1-PGC1alpha axis in db/db mice. Diabetologia 2013, 56:204-217.
23. Kitada M., Kume S., Imaizumi N., Koya D. Resveratrol improves oxidative stress and protects against diabetic nephropathy through normalization of Mn-SOD dysfunction in AMPK/SIRT1-independent pathway. Diabetes 2011, 60:634-643.
24. Kleniewska P., Piechota A., Skibska B., Goraca A. The NADPH oxidase family and its inhibitors. Arch. Immunol. Ther. Exp. (Warsz) 2012, 60:277-294.
25. Lee H.B., Yu M.R., Yang Y., Jiang Z., Ha H. Reactive oxygen species-regulated signaling pathways in diabetic nephropathy. J. Am. Soc. Nephrol 2003, 14:S241-S245.
26. Lee J.H., Kim J.H., Kim J.S., Chang J.W., Kim S.B., Park J.S., et al. AMP-activated protein kinase inhibits TGF-beta-, angiotensin II-, aldosterone-, high glucose-, and albumin-induced epithelial-mesenchymal transition. Am. J. Physiol. Renal Physiol 2013, 304:F686-F697.
27. Li J.M., Shah A.M. ROS generation by nonphagocytic NADPH oxidase: potential relevance in diabetic nephropathy. J. Am. Soc. Nephrol 2003, 14:S221-S226.
28. Liu Y. Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidney Int 2006, 69:213-217.
29. Liu Y. Cellular and molecular mechanisms of renal fibrosis. Nat. Rev. Nephrol 2011, 7:684-696.
30. Martinez J., Moreno J.J. Effect of resveratrol, a natural polyphenolic compound, on reactive oxygen species and prostaglandin production. Biochem. Pharmacol 2000, 59:865-870.
31. Muller G.A., Markovic-Lipkovski J., Frank J., Rodemann H.P. The role of interstitial cells in the progression of renal diseases. J. Am. Soc. Nephrol 1992, 2:S198-S205.
32. Nagarajan D., Melo T., Deng Z., Almeida C., Zhao W. ERK/GSK3beta/Snail signaling mediates radiation-induced alveolar epithelial-to-mesenchymal transition. Free Radic. Biol. Med 2012, 52:983-992.
33. Orallo F. Comparative studies of the antioxidant effects of cis- and trans-resveratrol. Curr. Med. Chem 2006, 13:87-98.
34. Rhyu D.Y., Yang Y., Ha H., Lee G.T., Song J.S., Uh S.T., et al. Role of reactive oxygen species in TGF-beta1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells. J. Am. Soc. Nephrol 2005, 16:667-675.
35. Sedeek M., Callera G., Montezano A., Gutsol A., Heitz F., Szyndralewiez C., et al. Critical role of Nox4-based NADPH oxidase in glucose-induced oxidative stress in the kidney: implications in type 2 diabetic nephropathy. Am. J. Physiol. Renal Physiol 2010, 299:F1348-F1358.
36. Spanier G., Xu H., Xia N., Tobias S., Deng S., Wojnowski L., et al. Resveratrol reduces endothelial oxidative stress by modulating the gene expression of superoxide dismutase 1 (SOD1), glutathione peroxidase 1 (GPx1) and NADPH oxidase subunit (Nox4). J. Physiol. Pharmacol 2009, 60(Suppl. 4):111-116.
37. Sun L., Xie P., Wada J., Kashihara N., Liu F.Y., Zhao Y., et al. Rap1b GTPase ameliorates glucose-induced mitochondrial dysfunction. J. Am. Soc. Nephrol 2008, 19:2293-2301.
38. Sun L., Kondeti V.K., Xie P., Raparia K., Kanwar Y.S. Epac1-mediated, high glucose-induced renal proximal tubular cells hypertrophy via the Akt/p21 pathway. Am. J. Pathol 2011, 179:1706-1718.
39. Towler D.A. Mitochondrial ROS deficiency and diabetic complications: AMP[K]-lifying the adaptation to hyperglycemia. J. Clin. Invest 2013, 123:4573-4576.
40. Wang W.C., Liu S.F., Chang W.T., Shiue Y.L., Hsieh P.F., Hung T.J., et al. The effects of diosgenin in the regulation of renal proximal tubular fibrosis. Exp. Cell Res 2014, 323:255-262.
41. Wei J., Shi Y., Hou Y., Ren Y., Du C., Zhang L., et al. Knockdown of thioredoxin-interacting protein ameliorates high glucose-induced epithelial to mesenchymal transition in renal tubular epithelial cells. Cell. Signal 2013, 25:2788-2796.
42. Xiao L., Ge Y., Sun L., Xu X., Xie P., Zhan M., et al. Cordycepin inhibits albumin-induced epithelial-mesenchymal transition of renal tubular epithelial cells by reducing reactive oxygen species production. Free Radic. Res 2012, 46:174-183.
43. Xu Y., Nie L., Yin Y.G., Tang J.L., Zhou J.Y., Li D.D., et al. Resveratrol protects against hyperglycemia-induced oxidative damage to mitochondria by activating SIRT1 in rat mesangial cells. Toxicol. Appl. Pharmacol 2012, 259:395-401.
44. Yun J.M., Chien A., Jialal I., Devaraj S. Resveratrol up-regulates SIRT1 and inhibits cellular oxidative stress in the diabetic milieu: mechanistic insights. J. Nutr. Biochem 2012, 23:699-705.
45. Zeisberg M., Bonner G., Maeshima Y., Colorado P., Muller G.A., Strutz F., et al. Renal fibrosis: collagen composition and assembly regulates epithelial-mesenchymal transdifferentiation. Am. J. Pathol 2001, 159:1313-1321.
46. Zeisberg M., Hanai J., Sugimoto H., Mammoto T., Charytan D., Strutz F., et al. BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat. Med 2003, 9:964-968.
47. Zhang A., Jia Z., Guo X., Yang T. Aldosterone induces epithelial-mesenchymal transition via ROS of mitochondrial origin. Am. J. Physiol. Renal Physiol 2007, 293:F723-F731.
48. Zhang L., Pang S., Deng B., Qian L., Chen J., Zou J., et al. High glucose induces renal mesangial cell proliferation and fibronectin expression through JNK/NF-kappaB/NADPH oxidase/ROS pathway, which is inhibited by resveratrol. Int. J. Biochem. Cell Biol 2012, 44:629-638.
49. Zhong Z., Davidescu A., Ehren I., Ekberg K., Jornvall H., Wahren J., et al. C-peptide stimulates ERK1/2 and JNK MAP kinases via activation of protein kinase C in human renal tubular cells. Diabetologia 2005, 48:187-197.